Home/ Supplements/ Black Cohosh/ Cimi-Fem 80 mg

Cimi-Fem 80 mg

product on market Lozenge Source Naturals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Cimi-Fem 80 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Lozenge(s)
Serving Size
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 80.0mg (136 products)

Other Ingredients

Mannitol Sorbitol natural Chocolate flavor Hydroxypropyl Methylcellulose natural Peppermint flavor Silica Stearic Acid Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: 1 lozenge daily. For best results, allow to dissolve in the mouth before swallowing. May also be swallowed. For best results, use this product for at least 4 weeks.

Warnings & Precautions

Warning: Do not use if you are pregnant, may become pregnant, or breastfeeding.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

Formulation Notes

May help reduce hot flashes associated with menopause

Source Naturals Cimi-Fem offers you black cohosh as an extract standardized to 2.5% triterpene glycosides. Cimi-Fem contains a black cohosh, shown clinically to reduce some of the normal discomforts of menopause, including hot flashes and occasional anxiety. Cimi-Fem is delivered in a quick-dissolving chocolate peppermint flavored lozenge that does not have to be swallowed and is easy to take once daily.

Metadata

Product Details

UPC / SKU0 21078 01068 5
DSLD Entry Date2020-02-26
Product TypeBotanical
FormLozenge
DSLD ID213892
Data Updated2026-04-11
Research

Research Evidence

31
Research Sources
49
Avg Quality
23
Systematic Review
5
Meta Analysis
1
Rct
1
Openfda Safety
B [Efficacy of black cohosh extracts for improving low estrogen status induced by postoperative GnRHa treatment in patients with endometriosis: a systematic review]
Systematic Review Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2020 PubMed
B Black cohosh (Cimicifuga spp.) for menopausal symptoms
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
B Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause
Systematic Review BJOG : an international journal of obstetrics and gynaecology 2017 PubMed DOI
C Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract
Meta Analysis Menopause (New York, N.Y.) 2011 PubMed DOI
C Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence
Meta Analysis Climacteric : the journal of the International Menopause Society 2021 PubMed DOI
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2007 PubMed
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2011 PubMed
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2010 PubMed
C Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis
Meta Analysis Menopause (New York, N.Y.) 2023 PubMed DOI
C Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis
Meta Analysis Alternative therapies in health and medicine 2010 PubMed
View all evidence for Black Cohosh →
Compare

Similar Products

View all Black Cohosh products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.